Ball & Co Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42K Sell
410
-498
-55% -$44.5K 0.03% 44
2026
Q1
$65K Sell
908
-82
-8% -$6.32K 0.05% 35
2025
Q4
$78K Sell
990
-147
-13% -$11.6K 0.05% 35
2025
Q3
$85K Buy
1,137
+12
+1% +$822 0.06% 37
2025
Q2
$77K Buy
1,125
+11
+1% +$721 0.08% 29
2025
Q1
$75K Buy
1,114
+13
+1% +$778 0.08% 25
2024
Q4
$49K Buy
+1,101
New +$61.8K 0.04% 33

Other funds holding CVS

Ball & Co Wealth Management's CVS Position: Q2 2026 in Review

Ball & Co Wealth Management reduced its CVS Health (CVS) stake by 55% in Q2 2026, selling an estimated $44.5K and leaving 410 shares worth $42K. The position accounts for 0.03% of the portfolio, ranked #44.

Ball & Co Wealth Management first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $85K in Q3 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ball & Co Wealth Management held 410 shares of CVS Health worth $42K as of Q2 2026.
  • Ball & Co Wealth Management sold 498 CVS Health shares in Q2 2026, an estimated $44.5K.
  • CVS Health made up 0.03% of Ball & Co Wealth Management's portfolio in Q2 2026, its #44 holding.
  • Ball & Co Wealth Management first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • Ball & Co Wealth Management's CVS Health position peaked at $85K in Q3 2025.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ball & Co Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.